title: [Study of the function of coagulation, fibrinolysis and pulmonary vascular endothelium before and after experimental pulmonary thromboembolism in rabbits].
abstract: OBJECTIVE
  To study the functional changes and the significance of coagulation, fibrinolysis and pulmonary vascular endothelium before and after experimental pulmonary thromboembolism in rabbits.
  
  
  METHODS
  Rabbit pulmonary thromboembolism models by injection of auto-blood clots into femoral vein were used to observe the dynamical changes of activity of coagulation and fibrinolysis and endothelin-1 (ET-1), nitrogen monoxide (NO), von Willebrand factor (vWF) in blood.
  
  
  RESULTS
  Petechial and patchy hemorrhages were observed on the surfaces of embolic lungs. The injected blood clots and secondary thrombosis in the pulmonary arteries, inflammatory cell infiltration around alveoli, local hemorrhages in the alveoli and interstitial tissue could be found by microscopy. The concentration of D-dimer, ET-1 and vWF in blood were significantly elevated, and the tissue-type plasminogen activator (t-PA), NO and antithrombin III (AT-III) decreased significantly after embolism (P < 0.05). After administration of urokinase, the pathological injuries relieved, and the concentration of D-dimer was higher at 1 h and 2 h after embolization than that before embolization (P < 0.05), and reduced to the level of pre- embolization at 4 h after embolization. The levels of t-PA, NO and AT-III after embolization were lower than those before embolization (P < 0.05). The level of ET-1 was higher at 2 h after embolization (P < 0.05) and reduced to the level of pre-embolization at 4 h.
  
  
  CONCLUSIONS
  PTE has important impacts on coagulation, fibrinolysis and pulmonary vascular endothelial function. Thrombolysis with urokinase could keep the balance between coagulation and fibrinolysis and protect pulmonary vascular endothelial function.
authors.affiliation: Beijing Chaoyang Hospital-Beijing Institute of Respiratory Medicine, Capital University of Medical Science, Beijing 100020, China.
authors.forename: Bao-Sen
authors.initials: BS
authors.lastname: Pang
authors.forename: Chen
authors.initials: C
authors.lastname: Wang
authors.forename: Qin
authors.initials: Q
authors.lastname: Luo
authors.forename: Li-Ming
authors.initials: LM
authors.lastname: Zhang
authors.forename: Min
authors.initials: M
authors.lastname: Zhu
authors.forename: Yan-Ling
authors.initials: YL
authors.lastname: Mao
authors.forename: Xiu-Xia
authors.initials: XX
authors.lastname: Huang
authors.forename: Wen-Jing
authors.initials: WJ
authors.lastname: Guo
mesh_terms: D000818:Animals; D000990:Antithrombin III / Q000378:metabolism; D001777:Blood Coagulation / Q000502:physiology*; D019332:Endothelin-1 / Q000097:blood*; D004730:Endothelium, Vascular / Q000502:physiology*; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005342:Fibrinolysis; D008297:Male; D009569:Nitric Oxide / Q000097:blood; D011655:Pulmonary Embolism / Q000097:blood* / Q000503:physiopathology; D011817:Rabbits; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D019332:Endothelin-1; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D014841:von Willebrand Factor; D009569:Nitric Oxide; D000990:Antithrombin III; D014568:Urokinase-Type Plasminogen Activator